Charles Schwab’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.8M Buy
292,317
+4,994
+2% +$64.9K ﹤0.01% 2447
2025
Q1
$7.25M Sell
287,323
-3,431
-1% -$86.6K ﹤0.01% 2108
2024
Q4
$10M Buy
290,754
+5,425
+2% +$187K ﹤0.01% 2013
2024
Q3
$14.1M Buy
285,329
+62,507
+28% +$3.09M ﹤0.01% 1878
2024
Q2
$13.4M Buy
222,822
+29,078
+15% +$1.75M ﹤0.01% 1892
2024
Q1
$9.99M Buy
193,744
+3,407
+2% +$176K ﹤0.01% 1983
2023
Q4
$7.67M Buy
190,337
+8,003
+4% +$323K ﹤0.01% 2128
2023
Q3
$5.09M Buy
182,334
+111,403
+157% +$3.11M ﹤0.01% 2253
2023
Q2
$2.04M Buy
70,931
+10,155
+17% +$292K ﹤0.01% 2544
2023
Q1
$1.01M Buy
60,776
+7,464
+14% +$125K ﹤0.01% 2725
2022
Q4
$675K Buy
53,312
+1,214
+2% +$15.4K ﹤0.01% 2908
2022
Q3
$626K Buy
52,098
+3,522
+7% +$42.3K ﹤0.01% 2937
2022
Q2
$684K Buy
48,576
+6,106
+14% +$86K ﹤0.01% 2935
2022
Q1
$526K Buy
42,470
+19,835
+88% +$246K ﹤0.01% 3086
2021
Q4
$255K Buy
22,635
+2,457
+12% +$27.7K ﹤0.01% 3314
2021
Q3
$256K Buy
+20,178
New +$256K ﹤0.01% 3294